The cytokine receptor CRLF3 is a human neuroprotective EV-3 (Epo) receptor
Open Access
- 6 April 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 16
Abstract
The evolutionary conserved orphan cytokine receptor-like factor 3 (CRLF3) has been implicated in human disease, vertebrate hematopoiesis and insect neuroprotection. While its specific functions are elusive, experimental evidence points toward a general role in cell homeostasis. Erythropoietin (Epo) is a major regulator of vertebrate hematopoiesis and a general cytoprotective cytokine. Erythropoietic functions mediated by classical Epo receptor are understood in great detail whereas Epo-mediated cytoprotective mechanisms are more complex due to involvement of additional Epo receptors and a non-erythropoietic splice variant with selectivity for certain receptors. In the present study, we show that the human CRLF3 mediates neuroprotection upon activation with the natural Epo splice variant EV-3. We generated CRLF3 knock-out iPSC lines and differentiated them toward the neuronal lineage. While apoptotic death of rotenone-challenged wild type iPSC-derived neurons was prevented by EV-3, EV-3-mediated neuroprotection was absent in CRLF3 knock-out neurons. Rotenone-induced apoptosis and EV-3-mediated neuroprotection were associated with differential expression of pro-and anti-apoptotic genes. Our data characterize human CRLF3 as a receptor involved in Epo-mediated neuroprotection and identify CRLF3 as the first known receptor for EV-3.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (398214842, 499371712)
This publication has 92 references indexed in Scilit:
- Protective Effects of HBSP on Ischemia Reperfusion and Cyclosporine A Induced Renal InjuryJournal of Immunology Research, 2013
- Uncovering genes required for neuronal morphology by morphology‐based gene trap screening with a revertible retrovirus vectorThe FASEB Journal, 2012
- Erythropoietin, erythropoiesis and beyondBiochemical Pharmacology, 2011
- Effects of recombinant human erythropoietin in normal humansThe Journal of Physiology, 2011
- Role of Erythropoietin Receptor Signaling in Parvovirus B19 Replication in Human Erythroid Progenitor CellsJournal of Virology, 2010
- Cardioprotection by a nonerythropoietic, tissue-protective peptide mimicking the 3D structure of erythropoietinProceedings of the National Academy of Sciences, 2010
- Optimal neuroprotection by erythropoietin requires elevated expression of its receptor in neuronsProceedings of the National Academy of Sciences, 2009
- Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietinProceedings of the National Academy of Sciences, 2008
- Raves and risks for erythropoietinCytokine & Growth Factor Reviews, 2008
- Evolution of Class I cytokine receptorsBMC Ecology and Evolution, 2007